# 68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study

> **NCT05228106** · — · RECRUITING · sponsor: **Centre de recherche du Centre hospitalier universitaire de Sherbrooke** · enrollment: 1000 (estimated)

## Conditions studied

- Solid Cancers

## Interventions

- **DIAGNOSTIC_TEST:** [68Ga]-PSMA-617

## Key facts

- **NCT ID:** NCT05228106
- **Lead sponsor:** Centre de recherche du Centre hospitalier universitaire de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-21
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05228106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05228106, "68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05228106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*